anmelden
SMI
13.426,68
PKT
+61,88
PKT
+0,46
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.10.15 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 30.10.15 | Swiss Re buy | Citigroup Corp. | |
| 30.10.15 | UBS Neutral | UBS AG | |
| 29.10.15 | Swiss Re buy | S&P Capital IQ | |
| 29.10.15 | Swiss Re kaufen | DZ-Bank AG | |
| 29.10.15 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 29.10.15 | Richemont overweight | JP Morgan Chase & Co. | |
| 28.10.15 | Novartis Halten | Independent Research GmbH | |
| 28.10.15 | Novartis Outperform | Bernstein Research | |
| 28.10.15 | Novartis buy | Kepler Cheuvreux | |
| 28.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 28.10.15 | Novartis Hold | Deutsche Bank AG | |
| 28.10.15 | UBS Neutral | JP Morgan Chase & Co. | |
| 28.10.15 | Novartis Equal weight | Barclays Capital | |
| 28.10.15 | Richemont Outperform | BNP PARIBAS | |
| 28.10.15 | Richemont buy | Goldman Sachs Group Inc. | |
| 28.10.15 | Roche buy | UBS AG | |
| 28.10.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
| 27.10.15 | Novartis Hold | S&P Capital IQ | |
| 26.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 26.10.15 | Richemont overweight | JP Morgan Chase & Co. | |
| 26.10.15 | Givaudan overweight | JP Morgan Chase & Co. | |
| 23.10.15 | Roche overweight | JP Morgan Chase & Co. | |
| 23.10.15 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.10.15 | ABB (Asea Brown Boveri) Neutral | Nomura | |
| 23.10.15 | Swiss Re buy | Citigroup Corp. | |
| 23.10.15 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 22.10.15 | UBS Verkaufen | Bankhaus Lampe KG | |
| 22.10.15 | UBS overweight | JP Morgan Chase & Co. | |
| 22.10.15 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 22.10.15 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 22.10.15 | Roche buy | Kepler Cheuvreux | |
| 22.10.15 | UBS Neutral | UBS AG | |
| 22.10.15 | UBS buy | Nomura | |
| 22.10.15 | Novartis Outperform | BNP PARIBAS | |
| 22.10.15 | UBS Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.10.15 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
| 22.10.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 22.10.15 | ABB (Asea Brown Boveri) buy | HSBC |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.